BUFFALO, N.Y. — Dealing with her 5-year-old son's cancer is "a terrifying thing" says Katie Tingley.

Alex Tingley was just diagnosed with acute lymphoblastic leukemia in December.

His treatment includes the drug Vincristine, a medication first approved for use by the FDA back in 1963. But this year Teva, one of two manufacturers of the drug, announced it was discontinuing production.

That left Pfizer as the lone drug-maker producing Vincristine. Suddenly, supplies were short and Katie Tingley wondered what this meant for her son.

“I would ask the drug companies to think about their kids and their families and if there was anything they could do to make these drugs available," Katie Tingley said.

Rep. Brian Higgins wants drug companies to do more than think. The Buffalo congressman wants companies to be required to make medications deemed essential.

“When people are facing a critical health situation these drugs should be there for them," says Higgins.

Prescription drug shortages are becoming increasingly common in the U.S. Last year, FDA Commissioner Scott Gottlieb indicated that creating a federally enforced "essential medicines list" was under consideration.

Gottlieb said in July of 2018 that a combination of federal regulation and incentives may be a possible solution to prescription shortages.

The FDA is set to produce a report, by the end of the year, on how to stem drug shortages.   

RELATED: FDA approves 'breakthrough' drug for cystic fibrosis

RELATED: Group calls for reform amid rises in prescription drug costs